{"transactions":[{"id":736200,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T20:20:06.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":11389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":11389,"derivative":{"exercise_price":49.56,"expiration_date":"2036-06-15","underlying":"Common Stock","underlying_shares":11389},"source":{"system":"sec-edgar","filing":"0001691218-26-000002","document":"wk-form4_1781641202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000169121826000002/wk-form4_1781641202.xml","form_type":"4"}},{"id":736199,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T20:20:06.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":2265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":5306,"source":{"system":"sec-edgar","filing":"0001691218-26-000002","document":"wk-form4_1781641202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000169121826000002/wk-form4_1781641202.xml","form_type":"4"}},{"id":1109803,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-16T22:07:53.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":15372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 12, 2026 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":15372,"derivative":{"exercise_price":34.46,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":15372},"source":{"system":"sec-edgar","filing":"0001691218-25-000003","document":"wk-form4_1750111667.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000169121825000003/wk-form4_1750111667.xml","form_type":"4"}},{"id":1109802,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T22:07:53.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":3041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 12, 2026 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":3041,"source":{"system":"sec-edgar","filing":"0001691218-25-000003","document":"wk-form4_1750111667.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000169121825000003/wk-form4_1750111667.xml","form_type":"4"}},{"id":1460047,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T22:12:47.000Z","date":"2024-07-02","kind":"grant","planned":false,"acquired":true,"shares":16760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option shall vest over 36 months, 1/3 of which will vest on July 2, 2025 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date."}],"balance_after":16760,"derivative":{"exercise_price":76.06,"expiration_date":"2034-07-01","underlying":"Common Stock","underlying_shares":16760},"source":{"system":"sec-edgar","filing":"0001649094-24-000031","document":"wk-form4_1720044761.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000164909424000031/wk-form4_1720044761.xml","form_type":"4"}},{"id":1465818,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Ordinary Shares","published_at":"2024-07-01T21:02:06.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":660000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from GBP0.13 based on an exchange rate of $U.S. 1.263714 to GBP1.00. The actual exercise price will be the pounds sterling amount."}],"balance_after":660000,"derivative":{"exercise_price":0.16,"exercise_date":"2025-07-01","expiration_date":"2034-07-01","underlying":"Ordinary Shares","underlying_shares":660000},"source":{"system":"sec-edgar","filing":"0001104659-24-076891","document":"tm2418639-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000110465924076891/tm2418639-3_4seq1.xml","form_type":"4"}},{"id":1839739,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Ordinary Shares","published_at":"2023-07-03T21:04:04.000Z","date":"2023-07-03","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from GBP0.12 based on an exchange rate of $U.S. 1.270841 to GBP1.00. The actual exercise price will be the pounds sterling amount."}],"balance_after":500000,"derivative":{"exercise_price":0.16,"exercise_date":"2024-07-03","expiration_date":"2033-07-03","underlying":"Ordinary Shares","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-23-077670","document":"tm2320409-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000110465923077670/tm2320409-6_4seq1.xml","form_type":"4"}},{"id":2217350,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Ordinary Shares","published_at":"2022-07-01T21:02:44.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from GBP0.23 based on an exchange rate of $U.S. 1.216007 to GBP1.00. The actual exercise price will be the pounds sterling amount."}],"balance_after":500000,"derivative":{"exercise_price":0.28,"exercise_date":"2023-07-01","expiration_date":"2032-07-01","underlying":"Ordinary Shares","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-22-076898","document":"tm2220260-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000110465922076898/tm2220260-5_4seq1.xml","form_type":"4"}},{"id":2644817,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Ordinary Shares","published_at":"2021-07-02T21:03:01.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":379788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from GBP0.51 based on an exchange rate of $U.S. 1.3807 to GBP1.00. The actual exercise price will be the pounds sterling amount."}],"balance_after":379788,"derivative":{"exercise_price":0.71,"exercise_date":"2022-07-01","expiration_date":"2031-07-01","underlying":"Ordinary Shares","underlying_shares":379788},"source":{"system":"sec-edgar","filing":"0001104659-21-088971","document":"tm2121284-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000110465921088971/tm2121284-5_4seq1.xml","form_type":"4"}},{"id":3095295,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Ordinary Shares","published_at":"2020-07-01T21:09:26.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":196186,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from GBP1.35 based on an exchange rate of $U.S. 1.2387 to GBP1.00.  The actual exercise price will be the pounds sterling amount."}],"balance_after":196186,"derivative":{"exercise_price":1.67,"exercise_date":"2021-07-01","expiration_date":"2030-07-01","underlying":"Ordinary Shares","underlying_shares":196186},"source":{"system":"sec-edgar","filing":"0001104659-20-079788","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000110465920079788/a4.xml","form_type":"4"}},{"id":3468156,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Ordinary Shares","published_at":"2019-07-03T21:00:49.000Z","date":"2019-07-02","kind":"grant","acquired":true,"shares":240541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from GBP0.48 based on an exchange rate of $U.S. 1.2638 to GBP1.00.  The actual exercise price will be the pounds sterling amount."}],"balance_after":240541,"derivative":{"exercise_price":0.61,"exercise_date":"2020-07-02","expiration_date":"2029-07-02","underlying":"Ordinary Shares","underlying_shares":240541},"source":{"system":"sec-edgar","filing":"0001104659-19-039324","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000110465919039324/a4.xml","form_type":"4"}},{"id":3958087,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-04-24T20:30:26.000Z","date":"2018-04-20","kind":"exercise","acquired":false,"shares":6723,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vests December 1, 2017 and the remainder vests in equal quarterly installments over the following three years following December 1, 2017."}],"balance_after":120000,"derivative":{"exercise_price":49.74,"expiration_date":"2026-11-30","underlying":"Common Stock","underlying_shares":6723},"source":{"system":"sec-edgar","filing":"0001609351-18-000038","document":"wf-form4_152460181304900.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000160935118000038/wf-form4_152460181304900.xml","form_type":"4"}},{"id":3958086,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-04-24T20:30:26.000Z","date":"2018-04-20","kind":"sale","acquired":false,"shares":6723,"price":82.5,"value":554647.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2017."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001609351-18-000038","document":"wf-form4_152460181304900.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000160935118000038/wf-form4_152460181304900.xml","form_type":"4"}},{"id":3958085,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-04-24T20:30:26.000Z","date":"2018-04-20","kind":"exercise","acquired":true,"shares":6723,"price":49.74,"value":334402.02,"ownership":{"direct":true},"balance_after":6723,"source":{"system":"sec-edgar","filing":"0001609351-18-000038","document":"wf-form4_152460181304900.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000160935118000038/wf-form4_152460181304900.xml","form_type":"4"}},{"id":3960124,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-04-19T20:23:57.000Z","date":"2018-04-18","kind":"exercise","acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% vests December 1, 2017 and the remainder vests in equal quarterly installments over the following three years following December 1, 2017."}],"balance_after":126723,"derivative":{"exercise_price":49.74,"expiration_date":"2026-11-30","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001609351-18-000032","document":"wf-form4_152416939151242.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000160935118000032/wf-form4_152416939151242.xml","form_type":"4"}},{"id":3960123,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-04-19T20:23:57.000Z","date":"2018-04-17","kind":"exercise","acquired":false,"shares":2277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% vests December 1, 2017 and the remainder vests in equal quarterly installments over the following three years following December 1, 2017."}],"balance_after":137723,"derivative":{"exercise_price":49.74,"expiration_date":"2026-11-30","underlying":"Common Stock","underlying_shares":2277},"source":{"system":"sec-edgar","filing":"0001609351-18-000032","document":"wf-form4_152416939151242.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000160935118000032/wf-form4_152416939151242.xml","form_type":"4"}},{"id":3960122,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-04-19T20:23:57.000Z","date":"2018-04-18","kind":"sale","acquired":false,"shares":11000,"price":82.53,"value":907830.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $82.50 to $82.68, inclusive.  The reporting person undertakes to provide to Spark Therapeutics, Inc., any security holder of Spark Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001609351-18-000032","document":"wf-form4_152416939151242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000160935118000032/wf-form4_152416939151242.xml","form_type":"4"}},{"id":3960121,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-04-19T20:23:57.000Z","date":"2018-04-18","kind":"exercise","acquired":true,"shares":11000,"price":49.74,"value":547140.0,"ownership":{"direct":true},"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001609351-18-000032","document":"wf-form4_152416939151242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000160935118000032/wf-form4_152416939151242.xml","form_type":"4"}},{"id":3960120,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-04-19T20:23:57.000Z","date":"2018-04-17","kind":"sale","acquired":false,"shares":2277,"price":82.5,"value":187852.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2017."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001609351-18-000032","document":"wf-form4_152416939151242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000160935118000032/wf-form4_152416939151242.xml","form_type":"4"}},{"id":3960119,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-04-19T20:23:57.000Z","date":"2018-04-17","kind":"exercise","acquired":true,"shares":2277,"price":49.74,"value":113257.98,"ownership":{"direct":true},"balance_after":2277,"source":{"system":"sec-edgar","filing":"0001609351-18-000032","document":"wf-form4_152416939151242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000160935118000032/wf-form4_152416939151242.xml","form_type":"4"}},{"id":3963273,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-04-16T21:52:22.000Z","date":"2018-04-12","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vests December 1, 2017 and the remainder vests in equal quarterly installments over the following three years following December 1, 2017."}],"balance_after":140000,"derivative":{"exercise_price":49.74,"expiration_date":"2026-11-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001609351-18-000030","document":"wf-form4_152391552866539.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000160935118000030/wf-form4_152391552866539.xml","form_type":"4"}},{"id":3963272,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-04-16T21:52:22.000Z","date":"2018-04-12","kind":"sale","acquired":false,"shares":20000,"price":77.51,"value":1550200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $77.50 to $77.56, inclusive.  The reporting person undertakes to provide to Spark Therapeutics, Inc., any security holder of Spark Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001609351-18-000030","document":"wf-form4_152391552866539.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000160935118000030/wf-form4_152391552866539.xml","form_type":"4"}},{"id":3963271,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-04-16T21:52:22.000Z","date":"2018-04-12","kind":"exercise","acquired":true,"shares":20000,"price":49.74,"value":994800.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001609351-18-000030","document":"wf-form4_152391552866539.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000160935118000030/wf-form4_152391552866539.xml","form_type":"4"}},{"id":4093706,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2018-01-23T00:04:58.000Z","date":"2018-01-18","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutic common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning January 18, 2019.  Vested shares will be delivered to the reporting person annually on the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning January 18, 2019.  Vested shares will be delivered to the reporting person annually on the vesting date."}],"balance_after":17500,"derivative":{"underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001609351-18-000013","document":"wf-form4_151666588407746.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000160935118000013/wf-form4_151666588407746.xml","form_type":"4"}},{"id":4093705,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-01-23T00:04:58.000Z","date":"2018-01-18","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vests January 18, 2019 and the remainder vests in equal annual installments over the following three years."}],"balance_after":35000,"derivative":{"exercise_price":50.55,"expiration_date":"2028-01-17","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001609351-18-000013","document":"wf-form4_151666588407746.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000160935118000013/wf-form4_151666588407746.xml","form_type":"4"}},{"id":4093703,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-01-23T00:03:04.000Z","date":"2017-12-11","kind":"sale","acquired":false,"shares":18,"price":46.33,"value":833.94,"ownership":{"direct":false,"nature":"By mother-in-law"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects transactions occurring in a brokerage account managed by an investment advisor who maintained discretionary authority over the account. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001609351-18-000009","document":"wf-form4_151666576955298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000160935118000009/wf-form4_151666576955298.xml","form_type":"4"}},{"id":4093702,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2018-01-23T00:03:04.000Z","date":"2017-12-08","kind":"purchase","acquired":true,"shares":18,"price":73.48,"value":1322.64,"ownership":{"direct":false,"nature":"By mother-in-law"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects transactions occurring in a brokerage account managed by an investment advisor who maintained discretionary authority over the account. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":18,"source":{"system":"sec-edgar","filing":"0001609351-18-000009","document":"wf-form4_151666576955298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000160935118000009/wf-form4_151666576955298.xml","form_type":"4"}},{"id":4533505,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":37690,"kind":"person","name":"Furey John","position":1,"cik":"0001691218","reported_name":"Furey John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-12-05T21:41:54.000Z","date":"2016-12-01","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vests December 1, 2017 and the remainder vests in equal quarterly installments over the following three years."}],"balance_after":160000,"derivative":{"exercise_price":49.74,"expiration_date":"2026-11-30","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001609351-16-000115","document":"wf-form4_148097409600576.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691218/000160935116000115/wf-form4_148097409600576.xml","form_type":"4"}}]}